SEMA3E and systemic sclerosis: Thus, the evidence that serum levels of Sema3E may reflect the severity of SSc-related microvascular disease may pave the way for future studies that are aimed at assessing this neuroendothelial molecule in the circulation of patients with different pathologies that are characterized by either an excess or lack of angiogenesis.